All lobbying filings

Arnold & Porter Kaye Scholer LLP

Arnold & Porter Kaye Scholer LLP filed a Q4 report for Genetix Biotherapeutics, Inc. on January 14, 2026, reporting $60,000 in lobbying income.

Lobbying for Genetix Biotherapeutics, Inc. · Biotechnology and pharmaceutical company.

As filed: ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.

All filings by Arnold & Porter Kaye Scholer LLP · Everything Genetix Biotherapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.